Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The Annals of Thoracic Surgery|July 6, 2000
S-100 after correction of congenital heart defects in neonates: is it a reliable marker for cerebral damage?M A Erb, M K Heinemann, H P Wendel, et al.
Zeitschrift Fur Kardiologie|December 1, 1995
[Improvement of perioperative hemodynamics and gas exchange by inhalation of nitric oxide in children with congenital cardiopulmonary defects]J Breuer, C I von Brenndorff, W Baden, et al.
Human Reproduction (Oxford, England)|August 6, 2009
Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndromeA Mueller, C Schöfl, R Dittrich, et al.
European Radiology|July 14, 2010
Effect of CT scan protocols on x-ray-induced DNA double-strand breaks in blood lymphocytes of patients undergoing coronary CT angiographyM A Kuefner, S Grudzenski, J Hamann, et al.
Ultraschall in Der Medizin (Stuttgart, Germany : 1980)|December 18, 2010
New diagnostic criteria in real-time elastography for the assessment of breast lesionsB R Adamietz, M Meier-Meitinger, P Fasching, et al.
Human Reproduction (Oxford, England)|October 22, 2022
Determinants of transplantation success with cryopreserved ovarian tissue: data from 196 women of the FertiPROTEKT networkL Lotz, J Bender-Liebenthron, R Dittrich, et al.
ESMO Open|October 26, 2024
Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancerK Seitz, C Goossens, H Huebner, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Mammographic Density and Prediction of Nodal Status in Breast Cancer PatientsC C Hack, L Häberle, K Geisler, et al.
Der Pathologe|November 9, 2018
[TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes]R Erber, A Hartmann, M W Beckmann, et al.
Geburtshilfe Und Frauenheilkunde|May 31, 2016
Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: the SUCCESS-A TrialL Schröder, B Rack, H Sommer, et al.
Pageof 4